Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Clinical trial NCT02711202 · COMPLETED
Trial details
- NCT number
- NCT02711202
- Sponsor
- Institute for Clinical and Experimental Medicine
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2009-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.